Concepedia

Author

Boel Engarås

Sahlgrenska University Hospital

Also Known As

B Engarås, B. Engarás, B. Engarås, Boel Engaras, Boel Engaräs, Boel Engarås

17

Publications

549

Citations

9

H-Index

12

Concepts

All Affiliations

Sahlgrenska University HospitalUmeå University
BE

About

Boel Engarås is an author at Sahlgrenska University Hospital specializing in surgical oncology, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

27

2

Pathology

2

2

27

3

Surgical Oncology

2

2

27

4

Health Sciences

1

1

16

5

Gastroenterology

1

1

11

Boel Engarås

×

9

Publications

547

Citations

9

H-Index

YearCitations

Results of Screening, Rescreening, and Follow-up in a Prospective Randomized Study for Detection of Colorectal Cancer by Fecal Occult Blood Testing: Results for 68,308 Subjects

J Kewenter, Hans Brevinge, Boel Engarås,

Scandinavian Journal of Gastroenterology

1994

252

Prediagnostic Levels of Carcinoembryonic Antigen and CA 242 in Colorectal Cancer: A Matched Case-Control Study

Richard Palmqvist, Boel Engarås, G Lindmark,

Diseases of the Colon & Rectum

2003

77

The Yield of Flexible Sigmoidoscopy and Double-Contrast Barium Enema in the Diagnosis of Neoplasms in the Large Bowel in Patients with a Positive Hemoccult Test

J Kewenter, Hans Brevinge, Boel Engarås,

Endoscopy

1995

64

Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial

J Kewenter, Hans Brevinge, Boel Engarås,

Diseases of the Colon & Rectum

1994

46

Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial

Larsolof Hafström, Boel Engarås, Stig B. Holmberg,

Cancer

1994

37

Value of retesting subjects with a positive Hemoccult® in screening for colorectal cancer

J Kewenter, Boel Engarås, E. Haglind,

British journal of surgery

1990

22

Individual Cutoff Levels of Carcinoembryonic Antigen and CA 242 Indicate Recurrence of Colorectal Cancer With High Sensitivity

Boel Engarås

Diseases of the Colon & Rectum

2003

22

Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma

Ann Forslund, Boel Engarås, Christina Lönnroth,

International Journal of Oncology

2002

16

CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease

Boel Engarås, J Kewenter, Ola Nilsson,

European Journal of Surgical Oncology

2001

11

Page 1